All Press Releases and Corporate Updates
| |
Message from the CEO - 1Q'12 Overview
May 9, 2012
|
242.4 KB |
|
 |
Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
May 3, 2012
|
24.3 KB |
|
| |
NASHVILLE, Tenn., May 3, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced first quarter 2012 financial results.
Net Revenues: For the three months ended March 31, 2012, net revenues were $10.3 million, compared...
|
|
Cumberland Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 3, 2012
Apr 12, 2012
|
8.5 KB |
|
| |
NASHVILLE, Tenn., April 12, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release its first quarter 2012 results after the market closes on Thursday, May 3, 2012. A conference call and live Internet webcast will be held on Thursday, May 3, 2012, at 5:00 p.m. Eastern Time to discuss the results.
...
|
|
Cumberland Pharmaceuticals to Present at Needham Life Sciences Conference in New York on April 3, 2012
Mar 27, 2012
|
8.9 KB |
|
| |
NASHVILLE, Tenn., March 27, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the Needham Life Sciences Conference in New York at 2:00 p.m. Eastern Time on Tuesda...
|
|
Cumberland Pharmaceuticals Reports 2011 Annual Financial Results
Feb 29, 2012
|
27.9 KB |
|
| |
NASHVILLE, Tenn., Feb. 29, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced 2011 annual financial results.
Net Revenue: For the year ended December 31, 2011, net revenue increased to $51.1 million, up 11.5% compared with $...
|
|
Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
Feb 28, 2012
|
14.7 KB |
|
| |
NASHVILLE, Tenn., Feb. 28, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced it has entered into an exclusive agreement with China's Harbin Gloria Pharmaceuticals Co., Ltd. (SHE: 002437)for the commercialization of Acetadote® (acetylcysteine), its injectable drug used to treat acetaminophen overdose, and Caldo...
|
|
Cumberland Receives Acetadote® Patent Notice of Allowance
Feb 8, 2012
|
12.2 KB |
|
| |
NASHVILLE, Tenn., Feb. 8, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote® (acetylcysteine) Injection, which is used to treat acetaminophen poisoning. The new formulation...
|
|
Cumberland Pharmaceuticals to Announce 2011 Year End Financial Results on February 29, 2012
Feb 8, 2012
|
8.6 KB |
|
| |
NASHVILLE, Tenn., Feb. 8, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release 2011 year-end financial results after the market closes on Wednesday, February 29, 2012. A conference call and live Internet webcast will be held on Wednesday, February 29, 2012, at 5:00 p.m. Eastern Time to discuss th...
|
| |
Message from the CEO - 3Q'11 Overview
Nov 14, 2011
|
179.7 KB |
|
|
Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
Nov 3, 2011
|
32.9 KB |
|
| |
NASHVILLE, Tenn., Nov. 3, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced third quarter 2011 financial results.
Net Revenue: For the three months ended September 30, 2011, net revenue was $13.1 million, up from $1...
|
|
Cumberland Pharmaceuticals Ranks as one of the Fastest Growing Companies in North America on Deloitte's 2011 Technology Fast 500™
Oct 20, 2011
|
11.6 KB |
|
| |
NASHVILLE, Tenn., Oct. 20, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that it has been placed on Deloitte's 2011 Technology Fast 500™ list, an annual ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based o...
|
|
Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011
Oct 13, 2011
|
8.6 KB |
|
| |
NASHVILLE, Tenn., Oct. 13, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release third quarter 2011 financial results after the market closes on Thursday, November 3, 2011. A conference call and live Internet webcast will be held on Thursday, November 3, 2011, at 5:00 p.m. Eastern Time to discuss t...
|
|
Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
Oct 12, 2011
|
10.0 KB |
|
| |
NASHVILLE, Tenn., Oct. 12, 2011 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Rick S. Greene, a long-time financial advisor to the Company, has been appointed Chief Financial Officer, effective Tuesday, October 18. He has served as...
|
|
Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
Aug 31, 2011
|
8.1 KB |
|
| |
NASHVILLE, Tenn., Aug. 31, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Monday, September 19, 2011...
|
| |
Message from the CEO – 2Q'11 Overview
Aug 26, 2011
|
139.3 KB |
|
|
Cumberland Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference in Boston
Aug 25, 2011
|
8.1 KB |
|
| |
NASHVILLE, Tenn., Aug. 25, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Stifel Nicolaus 2011 Healthcare Conference at the Four Seasons in Boston on Thursday, Septemb...
|
|
Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
Aug 4, 2011
|
32.3 KB |
|
| |
NASHVILLE, Tenn., Aug. 4, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced second quarter 2011 financial results.
Net Revenue: For the three months ended June 30, 2011, net revenue was $14.4 million, up 34% from $1...
|
|
Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America
Aug 4, 2011
|
9.4 KB |
|
| |
NASHVILLE, Tenn., Aug. 4, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has executed a new senior credit agreement with Bank of America. Pursuant to the new agreement, the Company has increased its revolving line of credit to $10 million, which is expandable to $20 million. In addition, the maturity d...
|
|
Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
Jul 14, 2011
|
8.5 KB |
|
| |
NASHVILLE, Tenn., July 14, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release second quarter 2011 financial results after the market closes on Thursday, August 4, 2011. A conference call and live Internet webcast will be held on Thursday, August 4, 2011, at 5:00 p.m. Eastern Time to discuss the...
|
|
Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston
Jun 7, 2011
|
8.1 KB |
|
| |
NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Wells Fargo Securities Healthcare Conference in Boston at 2:30 p.m. Eastern Time on Wednesday,...
|
|
|
